Beigene Stock Price Prediction
| BGNE Stock | USD 215.00 8.84 4.29% |
Oversold Vs Overbought
34
Oversold | Overbought |
EPS Estimate Next Quarter (1.30) | EPS Estimate Current Year (5.68) | EPS Estimate Next Year (0.56) | Wall Street Target Price 280.0645 | EPS Estimate Current Quarter (1.20) |
Using BeiGene hype-based prediction, you can estimate the value of BeiGene from the perspective of BeiGene response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in BeiGene to buy its stock at a price that has no basis in reality. In that case, they are not buying BeiGene because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
BeiGene after-hype prediction price | USD 214.93 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
BeiGene |
BeiGene After-Hype Price Prediction Density Analysis
As far as predicting the price of BeiGene at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in BeiGene or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of BeiGene, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
BeiGene Estimiated After-Hype Price Volatility
In the context of predicting BeiGene's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on BeiGene's historical news coverage. BeiGene's after-hype downside and upside margins for the prediction period are 212.29 and 217.57, respectively. We have considered BeiGene's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
BeiGene is very steady at this time. Analysis and calculation of next after-hype price of BeiGene is based on 3 months time horizon.
BeiGene Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as BeiGene is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading BeiGene backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with BeiGene, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.25 | 2.64 | 0.07 | 0.02 | 8 Events / Month | 3 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
215.00 | 214.93 | 0.03 |
|
BeiGene Hype Timeline
BeiGene is currently traded for 215.00. The entity has historical hype elasticity of -0.07, and average elasticity to hype of competition of 0.02. BeiGene is estimated to decline in value after the next headline, with the price expected to drop to 214.93. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.03%, whereas the daily expected return is currently at 0.25%. The volatility of related hype on BeiGene is about 2808.51%, with the expected price after the next announcement by competition of 215.02. About 19.0% of the company shares are held by company insiders. The company recorded a loss per share of 8.18. BeiGene had not issued any dividends in recent years. Given the investment horizon of 90 days the next estimated press release will be in about 8 days. Check out BeiGene Basic Forecasting Models to cross-verify your projections.BeiGene Related Hype Analysis
Having access to credible news sources related to BeiGene's direct competition is more important than ever and may enhance your ability to predict BeiGene's future price movements. Getting to know how BeiGene's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how BeiGene may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TFFP | Tff Pharmaceuticals | (0.13) | 4 per month | 0.00 | (0.13) | 11.28 | (12.99) | 95.77 | |
| ELYM | Eliem Therapeutics | 0.25 | 4 per month | 0.00 | (0.19) | 6.21 | (9.35) | 34.87 | |
| INBX | Inhibrx | 1.00 | 6 per month | 2.72 | 0.01 | 5.54 | (6.11) | 16.80 | |
| ELVN | Enliven Therapeutics | (0.55) | 9 per month | 2.18 | 0.01 | 5.84 | (4.07) | 12.96 | |
| MOLN | Molecular Partners AG | (0.10) | 5 per month | 4.92 | (0.01) | 9.38 | (7.97) | 52.92 |
BeiGene Additional Predictive Modules
Most predictive techniques to examine BeiGene price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for BeiGene using various technical indicators. When you analyze BeiGene charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About BeiGene Predictive Indicators
The successful prediction of BeiGene stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as BeiGene, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of BeiGene based on analysis of BeiGene hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to BeiGene's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to BeiGene's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 9.67 | 6.54 | 1.21 | 1.15 | Days Of Inventory On Hand | 54.53 | 53.48 | 399.78 | 419.77 |
Story Coverage note for BeiGene
The number of cover stories for BeiGene depends on current market conditions and BeiGene's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that BeiGene is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about BeiGene's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
BeiGene Short Properties
BeiGene's future price predictability will typically decrease when BeiGene's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of BeiGene often depends not only on the future outlook of the potential BeiGene's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BeiGene's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 104.4 M | |
| Cash And Short Term Investments | 3.2 B |
Complementary Tools for BeiGene Stock analysis
When running BeiGene's price analysis, check to measure BeiGene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeiGene is operating at the current time. Most of BeiGene's value examination focuses on studying past and present price action to predict the probability of BeiGene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeiGene's price. Additionally, you may evaluate how the addition of BeiGene to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |